Leerink Partners analyst Mani Foroohar maintained a Buy rating on RegenXBio (RGNX – Research Report) on February 20 and set a price target of ...

In a report released on February 19, Mike Kratky from Leerink Partners reiterated a Buy rating on Penumbra (PEN – Research Report), with a ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

Atyr PHARMA INC (NASDAQ:ATYR – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are currently covering the company, Marketbeat.com reports. Six equities ...

We recently compiled a list of the 10 Hot New Stocks to Buy Now. In this article, we are going to take a look at where ...

State of New Jersey Common Pension Fund D increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 41.7% in the 4th quarter, Holdings Channel.com reports. The institutional ...

UnitedHealth Group’s stock plummets after DOJ investigation report - UnitedHealth Group have had a tumultuous past year, ...